How New Therapies Are Changing The Future of Myeloma
Chimeric antigen receptor (CAR) t-cell therapy - The Bloodline with Blood Cancer United Podcast
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope for the future. In this episode, we speak to Dr. Nishi Shah of Montefiore Einstein Comprehensive Cancer Center in New York City. While the wide variety of therapies available to patients are discussed, this episode also focuses on the newest, cutting-edge therapies for myeloma, such as CAR T-cell therapy and bispecific antibodies.
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Multiple Myeloma
- CAR T-cell Therapy
- Bispecific Antibodies – Immunotherapy Booklet
- Stem Cell Transplant
- Multiple Myeloma and Agent Orange
Additional LLS Support Resources:
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Free booklets
- Clinical Trial Support Center
- Young Adult Resources
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Online chats
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by: AbbVie Inc.; Genentech, Inc. & Biogen; and Johnson & Johnson.
The post How New Therapies Are Changing The Future of Myeloma first appeared on The Bloodline with Blood Cancer United Podcast.